Avantax Planning Partners’s Lantern Pharma LTRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,640
Closed -$42.7K 447
2024
Q3
$42.7K Hold
11,640
﹤0.01% 434
2024
Q2
$54.4K Hold
11,640
﹤0.01% 458
2024
Q1
$102K Buy
+11,640
New +$102K ﹤0.01% 454